Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has submitted to the exchanges a quarterly certificate from its Registrar and Share Transfer Agent, MUFG Intime India (formerly Link Intime), as required under SEBI's Depositories Regulations. The certificate confirms that all share dematerialisation requests received from depository participants during the October–December 2025 quarter were processed and confirmed to the depositories. Physical share certificates received for demat were verified, cancelled (mutilated), and the depositories' names were updated as the registered owners in the company's member records within the prescribed timelines. The filing was signed by Company Secretary Aditi Bhatt on January 5, 2026.
This is a routine quarterly compliance filing and carries no material business or price impact. It simply reaffirms that the company's share transfer machinery is functioning smoothly and in line with SEBI rules.